AngelEye Health, founded with a mission to enhance family engagement in neonatal care, offers a comprehensive HIPAA-compliant tele-engagement platform. The company's core vision is to integrate parents seamlessly into their child's care team, thereby improving patient outcomes and family experiences. Their primary product suite includes tools that support care delivery workflows and facilitate a smooth transition home for neonatal patients. AngelEye Health focuses on the neonatal intensive care unit (NICU) market, aiming to revolutionize NICU care through technology-driven solutions.
Notable affiliations include the integration of NICU2Home, a significant step towards developing the industry's first evidence-based discharge coordination solution. This merger has positioned AngelEye Health as a leader in neonatal care innovation. The company has achieved substantial impact by empowering parents and equipping care teams, leading to improved patient outcomes and streamlined transitions from hospital to home. AngelEye Health continues to make strides in transforming neonatal care through its cutting-edge tele-engagement platform.